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Abstract
Background: The syncytialization of cytotrophoblast cells to syncytiotrophoblast is central to human placental
transport and hormone production. Many techniques for in vitro study of this process have been proposed and
new investigators to the field may find the literature in the field daunting. Here, we present a straightforward and
reliable method to establish this important model using modern but readily available tools and reagents.
Methods: Villous cytotrophoblast cells are obtained from term placenta using mild enzymatic degradation, Percoll
gradient centrifugation, negative magnetic cell sorting using an antibody against classical major histocompatibility
complex molecules and in vitro culture on a matrix-coated growth surface.
Results: The purity of isolated cytotrophoblast cells exceeds 98 % as assessed by cytokeratin-7 expression using flow
cytometry. Contamination by mesenchymal cells, extravillous trophoblast cells, leukocytes, Hofbauer and endothelial
cells is minimized (less than 2 % when analyzed for vimentin, HLA-G, CD45, CD163 and CD31 using flow cytometry).
Isolated cytotrophoblast cells began to aggregate into monolayers of mononucleated cells within about 12 h of
plating. By 72 h in culture, most cytotrophoblast cells have differentiated into syncytiotrophoblast as demonstrated
by a loss of intercellular E-cadherin expression upon fusion into multinucleated syncytia. After 72 h in culture, nearly
every cultured cell expresses syncytiotrophoblast markers, including cytokeratin-7, human chorionic gonadotropin-β
(β-hCG) and the fusion-related proteins glial cell missing-1 (GCM-1) and syncytin.
Conclusions: We present an efficient and reliable method for isolating of cytotrophoblast cells with high purity and
complete differentiation into syncytiotrophoblast in vitro.
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Background
Placental villous syncytiotrophoblast mediates maternal-
fetal transfer of nutrients critical for fetal growth and
development. This highly specialized epithelium also
performs a number of other functions including preg-
nancy hormone production and secretion [1]. The syn-
cytiotrophoblast arises from fusion and differentiation of
the underlying mitotically active cytotrophoblast cells
[2]. This process is characterized by morphological and
biochemical differentiation. The morphological differen-
tiation is defined by the fusion of mononucleated
cytotrophoblast cells with adjacent syncytium, while the
biochemical differentiation is characterized by the pro-
duction of hormones such as human chorionic gonado-
tropin (hCG) and human placental lactogen (hPL) [3].
The importance of syncytiotrophoblast for the progres-
sion of normal pregnancy is highlighted by the fact that
its dysregulation is linked to pregnancy complications
associated with maternal and/or fetal morbidity and
mortality, including preeclampsia [4–6] and fetal growth
restriction [7, 8].
The ability to readily and reproducibly obtain non-
immortalized human cytotrophoblast cells and syncytio-
trophoblast are necessary for the study of placental func-
tion and of the roles of each of these cellular components
in the normal physiology and pathologies of human
* Correspondence: schustd@health.missouri.edu
1Department of Obstetrics, Gynecology and Women’s Health, University of
Missouri School of Medicine, 500 N. Keene Street, Columbia, MO, USA
Full list of author information is available at the end of the article
© 2015 Li and Schust. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Li and Schust Reproductive Biology and Endocrinology  (2015) 13:71 
DOI 10.1186/s12958-015-0070-8
reproduction. Because of its syncytial structure, it is inher-
ently difficult to directly isolate syncytiotrophoblast. There-
fore, the first step in the production of cultured villous
syncytiotrophoblast has been to isolate its undifferentiated
in vivo precursor, villous cytotrophoblast cells.
Almost all current methods for isolation and culture
of placental cytotrophoblast cells are derived from the
classic work of Kilman et al, which was published in
1986 [9]. Since that time, improvements in digestion
agents have allowed investigators to move away from the
fairly harsh conditions of trypsin-mediated tissue diges-
tion [10, 11], although the use of Percoll density gradi-
ents for initial isolation of appropriate cell populations
post-digestion remains standard. The intervening years
have also allowed the introduction of very specific tools
for positive and negative antibody-mediated separation
of cytotrophoblast cells from non-trophoblast-derived
contaminants [12, 13]. The many permutations of these
approaches that can be found in the existing literature
make it difficult to choose a method for the purification
of villous trophoblast cells from normal human placenta
that will be reproducible, efficient and reliable.
In this study, we describe an optimized method for
isolation and culture of villous trophoblast from human
term placenta that meets these requirements. The methods
are straightforward and reproducibly obtain cytotropho-
blast cells with high purity and viability. These cells can be
easily maintained under common culture conditions and
will differentiate over the course of a few days into multi-
nucleated cells that express cytokeratin-7, β-hCG and fu-
sion proteins characteristic of syncytiotrophoblast cells. In
addition to their utility in the study of placental differenti-
ation and cytotrophoblast fusion into syncytiotrophoblast,
the cultured cytotrophoblast cells and syncytiotrophoblast
obtained using these methods could be used in combin-
ation with other in vitro cell models to study a variety of
other aspects of placental function in vitro, including
trophoblast-endometrial interactions during normal and
abnormal implantation, reproductive immunology, placen-
tal endocrinology, trophoblast/endometrial growth factor
and cytokine metabolism, and even basic mechanisms of
cell differentiation.
Methods
This study was approved by University of Missouri
Health Sciences Institutional Review Board. The experi-
mental procedures were performed between July 2014
and May 2015.
Reagents
Dispase II, collagenase I, Dulbecco's phosphate-buffered
saline (DPBS) without calcium and magnesium, Dulbecco’s
Modified Eagle’s Medium (DMEM), penicillin and strepto-
mycin, fetal bovine serum (FBS), bovine serum albumin
(BSA), Alexa Fluor® 488 donkey anti-rabbit IgG, Alexa
Fluor® 488 donkey anti-goat IgG, Alexa Fluor® 594 donkey
anti-rabbit IgG and Alexa Fluor® 488 donkey anti-mouse
IgG (H+ L) were obtained from Life Technologies (Grand
Island, NY, USA). PE-conjugated anti-HLA-ABC, anti-PE
microbeads and MACS separation buffer were purchased
from Miltenyi Biotec (Bergisch Gladbach, Germany).
APC-conjugated anti-HLA-G, APC/Cy7-conjugated anti-
CD45, PE/Cy7-conjugated anti-CD163 and matched
fluorescence-labeled isotype control antibodies were
obtained from BioLegend (San Diego, CA, USA). PerCP-
eFluor® 710-conjugated anti-CD31 and the matched
fluorescence-labeled isotype control antibody were ob-
tained from eBioscience (San Diego, CA, USA). Alexa
Fluor® 488-conjugated anti-vimentin, PE-conjugated anti-
cytokeratin-7, matched fluorescence-labeled isotype con-
trol antibodies, fixation buffer, and permeabilization wash
buffer were purchased from BD Biosciences (San Jose,
CA, USA). Goat anti-human cytokeratin-7 and rabbit
anti-human syncytin were obtained from Santa Cruz
Biotechnology (Dallas, Texas, USA). Rabbit anti-human
β-hCG and mouse anti-human glial cell missing-1
(GCM1) were purchased from Abcam (Cambridge, UK).
Rabbit anti-human E-cadherin was purchased from Cell
Signaling (Danvers, MA, USA). DNase I was obtained
from Roche (Basel, Switzerland). Percoll was purchased
from GE Healthcare (Pittsburgh, PA, USA). Marigel was
obtained from Sigma-Aldrich (St. Louis, MO, USA).
VECTASHIELD® mounting media with DAPI was pur-
chased from Vector Laboratories (Burlingame, CA, USA).
Isolation protocol
Human term placentas were collected from normal vagi-
nal or cesarean deliveries performed by the faculty of the
Department of Obstetrics, Gynecology and Women's
Health at the Missouri Women’s and Children’s Hos-
pital, University of Missouri School of Medicine. All
samples were processed immediately following delivery.
Several cubic millimeters of the basal plate surface were
removed sharply. Villous tissue was gently scraped free
from vessels and connective tissue using the blunt edge
of a scalpel. After washing thoroughly with DPBS, the
tissue was cut into small pieces. Every wet gram of
minced tissue was digested three times in 5 ml of a di-
gestion enzyme medium containing 1 mg/ml Dispase II,
0.5 mg/ml collagenase I and 0.1 mg/ml DNase I in
DMEM at 37 °C for 20 min each cycle in a shaking
water bath. Enzymatic degradation was stopped by add-
ing an equal volume of complete DMEM containing
10 % FBS, 100 U/ml penicillin and 100 μg/ml strepto-
mycin. The mix was filtered through a 100 μm strainer
(Thermo Fisher Scientific, Waltham, MA, USA) and
then a 40 μm strainer (Thermo Fisher Scientific) to re-
move contaminating tissue debris. Cell suspensions were
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collected and centrifuged at 350 g for 10 min at 4 °C.
Cell pellets were resuspended in 5 ml of complete
DMEM, layered on the top of a preformed Percoll gradi-
ent (65 %, 55 %, 50 %, 45 %, 35 %, 30 % and 25 %) and
centrifuged at 730 g at 4 °C without braking for 30 min.
The layer between the 45 % and 35 % Percoll aliquots
containing trophoblast cells (density 1.050-1.060 g/ml)
was collected, suspended in complete DMEM and cen-
trifuged at 350 g at 4 °C for 10 min. The resulting cell
pellet was resuspended in PBS, cells were counted and
the suspension was re-centrifuged at 350 g at 4 °C for
10 min.
Immunopurification of cytotrophoblast cells
Before primary culture, non-trophoblast cell contami-
nants were depleted using a PE-conjugated HLA-ABC
antibody and anti-PE microbeads according to the man-
ufacturer’s instructions (Miltenyi Biotec). Briefly, cell
pellets were resuspended in 100 μl of MACS separation
buffer per 107 cells and incubated with 10 μl of PE-
conjugated anti-HLA-ABC antibody for 10 min at 4 °C.
After washing, the cells were resuspended in 80 μl of
buffer and incubated with 20 μl of anti-PE microbeads
for 15 min at 4 °C. Cell pellets were washed and resus-
pended in 500 μl of buffer. HLA-ABC+ cells were de-
pleted using an MS column and a MiniMACSTM
separator (Miltenyi Biotec). The remaining trophoblast
cell fraction was counted and cell viability was estimated
by Trypan blue exclusion.
Primary culture of isolated cytotrophoblast cells
Isolated cells were plated on a Matrigel-coated culture
surface at a density of 4 × 105 cells/cm2 in complete
DMEM at 37 °C in 5 % CO2. After allowing the cells to
attach for 4 h, medium and unattached cells were re-
moved to eliminate preformed syncytial fragments that
would not survive extended culture.
Flow cytometry
Aliquots of 106 cells in 50 μl DPBS were incubated with
APC-conjugated anti-HLA-G (5 μl), APC/Cy7-conjugated
anti-CD45 (5 μl), PE/Cy7-conjugated anti-CD163 (5 μl) or
PerCP-eFluor® 710-conjugated anti-CD31 (5 μl) antibodies
for 30 min at 4 °C. After washing twice with DPBS, cells
were fixed in a fixation buffer. For intracellular cytokine
staining, cells were fixed in a fixation buffer and incubated
for 10 min at room temperature. After washing with
DPBS, cells were resuspended in a permeabilization wash
buffer and incubated with Alexa Fluor® 488-conjugated
anti-vimentin (5 μl) and PE-conjugated anti-cytokeratin-7
(20 μl) antibodies. Isotype controls were established
using matched fluorescence-labeled isotype control anti-
bodies and equivalent immunostaining conditions. Immu-
nostained cells were analyzed on a CyAn ADP flow
cytometer (Beckman Coulter, Brea, CA, USA) using Sum-
mit 5.2 software (Beckman Coulter). The expression levels
of cytokeratin-7, vimentin, CD45, CD 163, HLA-G and
CD31 in purified cytotrophoblast cells were measured and
graphed.
Immunocytochemistry
Isolated primary cytotrophoblast cells were cultured for
72 h. Cells were then fixed in 4 % paraformaldehyde for
15 min at room temperature. After washing three times
with DPBS, cells were permeabilized with DPBS contain-
ing 0.1 % triton for 20 min at room temperature, then
incubated with DPBS containing 5 % BSA for 1 h at
room temperature to block nonspecific staining. Samples
were rinsed with DPBS and incubated with rabbit anti-
human E-cadherin (1/100), goat anti-human cytokeratin-
7 (1/100) and rabbit anti-human β-hCG (1/100), mouse
anti-human GCM1 (1/100) or rabbit anti-human syncy-
tin (1/100) in a humidified box overnight at 4 °C. Cells
were then washed three times with DPBS and incubated
with Alexa Fluor® 488 donkey anti-rabbit IgG (1/300),
Alexa Fluor® 488 donkey anti-goat IgG (1/300) and
Alexa Fluor® 594 donkey anti-rabbit IgG (1/300), Alexa
Fluor® 488 donkey anti-mouse IgG (H + L) (1/300) or
Alexa Fluor® 594 donkey anti-human rabbit IgG (1/300)
for 1 h at room temperature. After washing three times
with DPBS, the cells were mounted in VECTASHIELD®
mounting media with DAPI. Samples were observed
under a Leica TCP SP8 MP confocal laser-scanning
microscope (Leica Microsystems, Wetzlar, Germany) using
Leica LAS AF Lite software (Leica Microsystems).
Statistical analysis
All statistical analyses were performed using SPSS 19.0
software (IBM, Armonk, NY, USA). Data were analyzed
using one-way ANOVA with Bonferroni post-testing.
Results were expressed as mean ± SD. A p value of < 0.05
was considered significant.
Results
Comparison of yield and viability of purified cytotrophoblast
cells among diverse enzymatic digestion protocols
To determine which digestion protocol simultaneously
optimized yield and viability in the isolated cytotropho-
blast cells, we exposed placental tissue to trypsin alone
[10, 11] or in combination with other enzymes [14, 15],
as well as proteolytic enzymes other than trypsin for
various incubation times. As shown in Fig. 1, three di-
gestions for 20 min each using an enzymatic cocktail
composed of dispase II, collagenase I and DNase I
(Protocol 6) resulted in the best combination of yield
and cell viability. Using this protocol, the average yield
of purified cytotrophoblast cells was (1.11 ± 0.07) × 106
Li and Schust Reproductive Biology and Endocrinology  (2015) 13:71 Page 3 of 9
cells/gram tissue and average cell viability was 94.4 % ±
3.2 % as judged by Trypan blue exclusion (n = 6).
Cytotrophoblast cell purity after only Percoll isolation
The purity of primary cytotrophoblast cells was analyzed
based on the expression of cytokeratin-7 using flow
cytometry. The percentage of cells that expressed
cytokeratin-7 immediately after Percoll centrifugation
was only about 80 % (Fig. 2a). Approximately 8 % of the
cells expressed vimentin, a mesenchymal cell marker
used to identify non-trophoblast contaminants (Fig. 2b).
Contaminating leukocytes accounted for more than 5 %
of the isolated cells as assessed by the expression of the
pan leukocyte marker CD45 (Fig. 2c). Cells expressing
CD163, a specific marker of fetal macrophages (Hof-
bauer cells), accounted for about 3 % of the isolated cells
(Fig. 2d). Contamination by extravillous cytotrophoblast
cells expressing HLA-G was slightly more than 1 %
(Fig. 2e). Contaminating endothelial cells including fetal
endothelial cells expressing CD31 made up more than
4 % of isolated cells (Fig. 2f ).
Purity of cytotrophoblast cells after immunopurification
The percentage of cytokeratin-7 positive cytotrophoblast
cells exceeded 98 % after Percoll separation followed by
immunopurification (Fig. 3a). Contaminating mesenchy-
mal cells, leukocytes, Hofbauer cells, extravillous cyto-
trophoblast cells and endothelial cells comprised less
than 2 % of these doubly purified cells (Fig. 3b-f ).
Differentiation of cytotrophoblast cells into
syncytiotrophoblast in culture
Isolated cytotrophoblast cells began to aggregate into
monolayers of mononucleated cells within about 12 h of
plating. Immunofluorecent staining of E-cadherin pre-
sented at the boundaries of aggregated cells (Fig. 4a). By
72 h in culture, most cytotrophoblast cells had differen-
tiated into syncytiotroblast as demonstrated by a loss of
intercellular E-cadherin expression upon fusion into mul-
tinucleated syncytia (Fig. 4b). As shown in Fig. 5, nearly
every cell expressed both cytokeratin-7 and β-hCG
simutaneously after 72 h of culture, visually demonstrat-
ing the presence of syncytiotrophoblast and the high
purity of the isolated cells. In addition, strong staining
for the fusion transcript factor GCM1 (Fig. 6) and the
fusion protein syncytin (Fig. 7) could also be detected on all
of the cells in culture. Together with multinuclear morph-
ology, these expression patterns indicate the differentiation
of purified cytotrophoblast cells into syncytiotrophoblast.
Discussion
Isolation of viable mononuclear cytotrophoblast cells
with high purity from placental tissues is essential to any
reliable in vitro culture method that allows for subse-
quent differentiation into syncytiotrophoblast. Optimiz-
ing this isolation requires a delicate balance during the
initial enzymatic degradation of freshly isolated tissues.
In most isolation methods, trypsin is used either alone
[10, 11] or in combination with other enzymes [14, 15].
However, the use of trypsin for digestion has several
Fig. 1 Comparison of yield and viability of purified cytotrophoblast cells among a variety of enzymatic degradation protocols. Yield (a) and
viability (b) of purified cytotrophoblast cells using different enzymatic digestion protocols were assessed. Protocol 1: digestion three times in
0.25 % trypsin for 30 min each [10]; Protocol 2: digestion two times in 0.25 % trypsin for 10 min each [11]; Protocol 3: digestion in 0.125 % trypsin
and 0.2 mg/ml DNase I for 45 min [14]; Protocol 4: digestion three times in 0.125 % trypsin and 0.2 mg/ml DNase I for 30 min each [15]; Protocol
5: digestion three times in 1 mg/ml Dispase II, 0.5 mg/ml collagenase I and 0.1 mg/ml DNase I for 15 min each; Protocol 6: digestion three times
in 1 mg/ml Dispase II, 0.5 mg/ml collagenase I and 0.1 mg/ml DNase I for 20 min each; Protocol 7: digestion two times in 1 mg/ml Dispase II,
0.5 mg/ml collagenase I and 0.1 mg/ml DNase I for 30 min each. Data are presented as mean ± SD of six independent experiments
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Fig. 3 Purity of villous cytotrophoblast cells after immunopurification. The expression levels of cytokeratin-7 (a), vimentin (b), CD45 (c), CD163 (d),
HLA-G (e) and CD31 (f) in immunopurified cytotrophoblast cells were analyzed using flow cytometry. Gray shaded histogram: isotype-matched
negative control. Black line: specific antibody expression. Numbers indicate the percentages of particular antibody positive cells among isolated
cells (%). The depicted result is representative of four independent experiments
Fig. 2 Purity of villous cytotrophoblast cells after Percoll isolation. The expression levels of cytokeratin-7 (a), vimentin (b), CD45 (c), CD163 (d),
HLA-G (e) and CD31 (f) in Percoll-isolated cytotrophoblast cells were analyzed using flow cytometry. Gray shaded histogram: isotype-matched
negative control. Black line: specific antibody expression. Numbers indicate the percentages of particular antibody positive cells among isolated
cells (%). The depicted result is representative of four independent experiments
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drawbacks. When compared to milder digestion reagents,
trypsin exposure results in limited survival of isolated cells
after dispersion and collection [16]. Moreover, trypsin
may affect protein surface expression profiles on isolated
cytotrophoblast cells and thereby complicate immunopur-
ification and determination of cell purity. Such altered cell
surface profiles may also alter subsequent functional stud-
ies of the cytotrophoblast cells and/or syncytiotrophoblast.
Several proteolytic enzymes other than trypsin have been
used alone or in combination to digest placental villous
tissues in an effort to maximize the viability and surface
protein signatures of the isolated cells, including pronase
with DNase I [17], collagenase combined with DNase IV
and protease XIV [18], and dispase II combined with
DNase I [19].
Contamination of isolated cytotrophoblast cells by
stromal or other cells is minimized when the mildest
and shortest disaggregation conditions are employed.
The ideal enzymatic digestion would obtain the highest
possible yield and viability of the desired cells while min-
imizing collection of contaminating cells. In this study,
we compared the effects of trypsin (alone or in combin-
ation with DNase I) and the enzymatic cocktail (dispase
II, collagenase I and DNase I) under a variety of incuba-
tion times and digestion repeats in parallel experiments.
We found that dispase II in conjunction with collage-
nase I effectively but gently released cells from placental
tissue without significantly affecting cell viability. The
addition of DNase I was used to reduce the viscosity of
the digests and improve the efficiency of single cell
separation. In addition, the use of three 20 min cycles of
digestion with our enzymatic cocktail gave the highest
yield without significantly compromising cell viability.
To optimize efficiency and reliability, it is important to
obtain a true single-cell suspension before Percoll gradi-
ent centrifugation and subsequent magnetic cell separ-
ation. It has been previously shown that the majority of
the freshly isolated cytotrophoblast cells will have a
diameter of about 10 μm, although these cells may occa-
sionally be as large as 20-30 μm in diameter [2]. In our
optimized protocol, we used a 40-μm-pore strainer to
eliminate tiny tissue debris and extant syncytial fragments
Fig. 5 Expression of cytokeratin-7 and β-hCG in isolated trophoblast cells after 72 h in culture. a Primary trophoblast cells isolated from human
term placentas were culture for 72 h and stained with cytokeratin-7 (green). Nuclei were stained with DAPI (blue). b Primary trophoblast cells
isolated from human term placentas were culture for 72 h and stained with β-hCG (red). Nuclei were stained with DAPI (blue). c Merge of
cytokeratin-7 and β-hCG immunostaining images. Confocal microscopy, scale bar: 50 μm
Fig. 4 Expression of E-cadherin on isolated trophoblast cells. Primary trophoblast cells isolated from human term placentas were stained with
E-cadherin (green). Nuclei were stained with DAPI (blue). Confocal microscopy, scale bar: 50 μm. a Mononuclear cytotrophoblast cells aggregated
by 12 h in culture. b Most cytotrophoblast cells fused to form multinucleated syncytia by 72 h in culture
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before Percoll isolation. The density gradient is certainly
useful in separating red blood cells and remaining cellular
debris from the bulk of all other cells. However, use of a
density gradient alone isolates a fairly crude cellular
population with broad phenotypic variation and an
unacceptably high level of cellular contamination by
mesenchymal cells, leukocytes, Hofbauer cells and extra-
villous trophoblast cells (Fig. 2). Further immunopurifica-
tion is essential to reliably and efficiently isolate primary
cytotrophoblast cells.
To date, there appears to be no consensus regarding
which specific surface marker or markers should be used
to consistently isolate cytotrophoblast cells, although
Pötgens et al. [20] has presented a method for isolation
of villous cytotrophoblast cells based on positive immo-
noselection using an antibody against hepatocyte growth
factor activator inhibitor 1 (HAI-1) and magnetic separ-
ation. However, positive selection has a potential disad-
vantage in that cytotrophoblast cells may become
activated during the isolation process, perhaps compli-
cating subsequent functional studies. Others have used
immunomagnetic microspheres coated with antibodies
against specific antigens on the cell surface to deplete
cell harvest of non-trophoblastic cells before primary
culture. Douglas and King [13] were the first to report
the use of such negative immunopurification, employing
magnetic microspheres coated with antibodies against
HLA class I (anti-HLA-ABC) and HLA class II. Others
have depleted CD45+ cells [21], HLA-ABC+ cells and
CD45+ cells [22], CD9+ cells and CD45+ cells [23], CD45+
cells and HLA class II+ cells [12], CD3+ cells, CD49+ cells,
CD31+ cells, CD14+ cells and CD45RA+ cells [24]. The re-
action patterns of marker antibodies for non-trophoblastic
cells are listed in Table 1.
HLA-ABC antigens are expressed by all human nucle-
ated cells except villous cytotrophoblast cells and derivative
syncytiotrophoblast. As shown in Table 1, using beads-
coated anti-HLA-ABC antibody is sufficient to effectively
deplete non-trophoblastic cells during cytotrophoblast cell
isolation. Since each step of immunodepletion inevitably
decreases the overall yield of non-selected cells as well as
those reacting to the antibody bound to the microbead we
chose to include a single immunopurification step in our
final protocol.
Syncytial fragments do not attach to most growth sur-
faces and these can be removed by careful washing after
4 h of culture [25]. The aggregation of villous cytotropho-
blast cells, a necessary step before the cells fuse to form
syncytia, requires movement across the culture surface to
make contact with each other. A protein extracellular
matrix culture surface helps to allow cellular movement
[3]. In this study, we used Matrigel to improve cytotro-
phoblast cell aggregation and syncytialization.
The purity of isolated trophoblast cells and the nature
of contaminating cells should be assessed carefully when
working with these primary in vitro culture models. If
Fig. 6 Expression of GCM1 on isolated trophoblast cells after 72 h in culture. Primary trophoblast cells isolated from human term placentas were
culture for 72 h and stained with an antibody against GCM1 (green). Nuclei were stained with DAPI (blue). Confocal microscopy, scale bar: 50 μm
Fig. 7 Expression of syncytin on isolated trophoblast cells after 72 h in culture. Primary trophoblast cells isolated from human term placentas were
culture for 72 h and stained with an antibody against syncytin (red). Nuclei were stained with DAPI (blue). Confocal microscopy, scale bar: 50 μm
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the intention of the planned investigation is the study of
trophoblast cell differentiation, cytotrophoblast cell iso-
lation must aim for a highly purified yield. Assessment
of purity using flow cytometry is both objective and
quantitative. Here we evaluated the expression of the
intracellular marker cytokeratin-7 to check the purity of
isolated trophoblast cells since this trophoblast-specific
marker has been shown to be an accurate and reliable
marker for the identification of human villous tropho-
blast cells obtained from both early and term placenta
[24]. In our study, more than 98 % of purified cells
expressed cytokeratin-7. High purity was confirmed by
immunostaining with cytokeratin-7. Conversely, we
assessed the presence of contaminating cells using flow
cytometry and antibodies against the mesenchymal marker,
vimentin (expressed in fibroblasts, myofibroblasts, smooth
muscle cells and endothelial cells), the extravillous cytotro-
phoblast cell marker, HLA-G, the pan-leukocyte marker,
CD45, the Hofbauer cell marker, CD163 and the endothe-
lial cell marker, CD31. The total percentage of these
non-villous cytotrophoblast cell contaminants in our
preparations was less than 2 %.
Immunostaining with an anti-E-cadherin antibody
delineates surface membranes and allows distinction be-
tween fused, multinucleated syncytintrophoblast and
mononucleated cytotrophoblast cells. Cytotrophoblast
cells isolated from human term placenta were mono-
nuclear. Although these cells aggregated in culture
within 12 h after plating, they maintained distinct inter-
cellular borders. Most of these cells fused into multinu-
cleated cells after 72 h in culture as assessed by
morphology. To further assess the in vitro differentiation
of isolated cytotrophoblast cells into syncytiotrophoblast,
we used immunocytochemistry to demonstrate the sim-
ultaneous expression of cytokeratin-7 and β-hCG and
confocal microscopy. Although the presence of hormone-
secreting extravillous trophoblast cells that do not form
syncytia has been shown [26], we demonstrated using flow
cytometry that the presence of contaminating HLA-G
positive extravillous trophoblast cells in our highly puri-
fied villous cytotrophoblast cell populations was very
limited. Nearly all of the purified villous cytotrophoblast
cells differentiated into syncytiotrophoblast over 72 h in
culture when analyzed for the expression of cytokeratin-7
and β-hCG.
Trophoblast fusion in the placenta is essential to the
overall health of mother and child in humans. This
process may extend well into the third trimester of preg-
nancy, but is initiated at the very earliest stages of
human gestation. Abnormalities in this process during
implantation and the first several weeks of pregnancy
cannot be studied in vivo for ethical and logistical rea-
sons, but it may be these abnormalities that act as un-
derpinnings of several diseases of abnormal placentation,
including preeclampsia, fetal growth restriction and early
pregnancy loss of euploid embryos. Several regulatory
proteins have been shown to be involved in trophoblast
fusion. For example, syncytin is encoded by a human
endogenous retrovirus (HERV)-W element and plays a
central role in trophoblast fusion [15]. GCM1 is a
placenta-specific transcription factor that promotes
syncytin mRNA expression [27]. Almost all of the tropho-
blast cells in culture expressed GCM1 and syncytin,
further confirming differentiation of isolated villous
cytotrophoblast cells into syncytiotrophoblast.
Conclusions
We present here an optimized method for the isolation
of villous cytotrophoblast cells from chorionic villi ob-
tained from human term placenta. The isolation yields
cells of high purity and viability that readily and spontan-
eously differentiate into syncytiotrophoblast in culture.
Abbreviations
BSA: Bovine serum albumin; DMEM: Dulbecco’s modified eagle’s medium;
DPBS: Dulbecco's phosphate-buffered saline; FBS: Fetal bovine serum;
GCM1: Glial cell missing-1; HAI-1: Hepatocyte growth factor activator
inhibitor 1; hCG: Human chorionic gonadotropin; HERV: Human endogenous
retrovirus; hPL: Human placental lactogen.
Table 1 Reaction pattern of marker antibodies for non-trophoblastic cells
Antigen CT ST EVT Leukocytes Mesenchymal cells References
Fibroblasts, myofibroblasts,
smooth muscle cells
Endothelial cells Hofbauer cells
CD9 - - + + + + - [28, 29]
CD45 - - - + - - + [30]
FSA - - - - + + - [31]
HLA-I - - + + + + + [25]
HLA-G - - + - - - - [32]
HLA-II - - - + - - + [12]
Vimentin - - - + + + + [31]
CD163 - - - - - - + [23]
Abbreviations: FSA, fibroblast specific antigen; CK7, cytokerain-7; CT, cytotrophoblast cells; ST, syncytiotrophoblast; EVT, extravillous cytotrophoblast cells
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